WASHINGTON, D.C. - U.S. Sen. John Kennedy (R-La.) issued the following statement today after the Louisiana Committee on Parole rejected a medical treatment furlough for convicted murderer Clyde Y. Giddens:

“I am thankful that common sense prevailed and that the Louisiana Committee on Parole prioritized public safety and the victim’s suffering.  Mr. Giddens needs to remain in prison until he dies despite Gov. Edwards’ efforts to free dangerous inmates through his criminal justice reform package” said Sen. Kennedy.  “My prayers are with Earline Bamburg’s family.  I’m sorry that they had to relive this.”

###

WASHINGTON, D.C. – U.S. Sen. John Kennedy (R-La.) sent the following letter to the Louisiana Board of Pardons and Parole regarding convicted murderer Clyde Y. Giddens:

March 14, 2018

Louisiana Board of Pardons and Parole

P.O. Box 94304

Baton Rouge, La. 70802

Dear Board Members:

I write to oppose the early release of convicted murderer Clyde Y. Giddens.  It is my understanding that Mr. Giddens will come before the Committee on Parole Thursday from the Louisiana State Penitentiary at Angola, where he is serving a life sentence for the brutal murder of Mrs. Earline Bamburg. 

The only reason Mr. Giddens is even afforded the possibility of freedom is because of the early release measures within Gov. John Bel Edwards’ criminal justice reform program.  He has not earned a second chance.

Mr. Giddens pleaded guilty in 1964 to Mrs. Bamburg’s murder.  Mr. Giddens assaulted Mrs. Bamburg, stabbed her, burned her corpse and hacked off her arms and leg with a saw.  Later, he told a law enforcement officer that he laughed as he used the saw and fed her body parts to a stray dog.  Mr. Giddens said he got a thrill from watching the dog eat the body parts like they were “hamburger meat.”

At the time of her brutal death, Mrs. Bamburg was 36 years old.  Her family generously opted against pursuing the death penalty because they believed a life sentence was for life.  Mr. Giddens has repaid their kindness by seeking parole eligibility more than a dozen times.

Gov. Edwards’ so-called criminal justice reform package gave Mr. Giddens an undeserved gift by making limited-mobility offenders eligible for medical treatment furloughs.  According to news reports, Louisiana Department of Corrections Secretary James LeBlanc has recommended that Mr. Giddens receive a medical furlough.  Mr. Giddens apparently uses a wheelchair.  However, he is well enough to grant news interviews and lie about why he is behind bars.  Just last year, he told The Washington Post that he was in prison for killing a man during a fight.

A life sentence should be a life sentence, especially when the murder victim suffered the type of indignity that Mrs. Bamburg did.  Her family continues to mourn her loss.  They suffer further every time Mr. Giddens makes another grasp for freedom.  They fervently want him to remain in prison.  Their wishes should trump releasing Mr. Giddens purely to save a few nickels on medical expenses.

Thank you for your attention to this issue.

Sincerely,

John Kennedy

                                                                        U.S. Senate

cc: Gov. John Bel Edwards

      Louisiana Department of Corrections Secretary James LeBlanc

###

WASHINGTON, D.C. – U.S. Sens. John Kennedy (R-La.), Dick Durbin (D-Ill.), Dianne Feinstein (D-Calif.) and Chuck Grassley (R-Iowa), all members of the Senate Judiciary Committee, today introduced the Opioid Quota Reform Act of 2018.  This bipartisan legislation will enhance the Drug Enforcement Administration’s (DEA) existing opioid quota-setting authority by improving transparency and enabling the DEA to adjust quotas to prevent opioid diversion and abuse.

The DEA is responsible for establishing annual quotas determining the exact amount of each opioid drug that is permitted to be produced in the U.S. each year.  The DEA approved significant increases in aggregate opioid production quotas between 1993 and 2015, including a 39-fold increase for oxycodone and a 12-fold increase for hydrocodone.  Such increases occurred largely because current law directs the DEA to only consider certain factors when setting quotas — like past sales and estimated demand — but not other factors such as the impact of such opioid production on diversion, abuse rates or overdose deaths.  As a result, more than 14 billion opioid pills are put on the market each year — far more than necessary under current medical guidelines and enough for every adult American to have a one month’s prescription of addictive painkillers. 

Recognizing this problem, Attorney General Jeff Sessions has asked the DEA to evaluate whether changes are needed to its production quota process to address the disproportionate volume of opioid prescriptions issued each year in the United States.  

“Drug overdose deaths have nearly tripled since 1999, and the opioid epidemic costs Louisiana alone about $296 million annually.  Addiction is ripping apart families in every town across Louisiana.  It’s impacting people in every income bracket and stealing lives,” said Sen. Kennedy.  “We have to strike a balance between providing painkillers to people who need them while ensuring that doctors and patients understand how dangerously addictive these drugs are.  All it takes is a simple fall from a ladder to create a lifelong battle with painkiller addiction.  This is an epidemic that requires a battle plan if it’s going to be defeated.”

“Every day, more than 100 Americans die from an opioid overdose.  While we know that there are legitimate uses for opioid painkillers, we also know that these dangerous pills are being over-produced, over-prescribed, and over-dispensed,” said Sen. Durbin.  “The DEA plays an important gatekeeper role over the volume of opioids that can be produced each year.  And while the DEA has taken recent steps to lower opioid quotas, their ability to do so is limited.  Opioid quota reform is needed so the DEA can take important factors like diversion and abuse into account when setting quotas, rather than chasing the downstream consequences of this crisis.  And this bipartisan legislation will allow the DEA to do just that.  But our work is not done.  These quotas should continue to come down, doctors must be more judicious in their prescribing, drug companies must stop misleading the public about their products and we simply must do more to help those who are currently addicted get treatment.”

“We have a responsibility to better address the opioid epidemic, which took the lives of more than 42,000 Americans in 2016, by stopping addiction before it starts,” said Sen. Feinstein.  “I believe this bill strikes the right balance in maintaining access to medications for legitimate medical use and reducing the supply of opioids available to be diverted and abused.  I am confident that this bill can help reduce the astonishing number of drug overdose deaths in our country, and am pleased to be a cosponsor.”

“The opioid crisis will only be beat back if we use every tool possible to fight against it. This legislation is one of those tools,” Sen. Grassley said.  “Improving transparency in setting opioid quotas is critical to curbing opioid abuse while ensuring those who need opioids to treat illnesses and manage pain will still have lawful access to their medicine.  As Chairman of Judiciary Committee and the Narcotics Control Caucus, I care deeply about finding a solution to the opioid epidemic, and this legislation is a step in the right direction.”

In 2016 — after years of dramatic increases to the volume of opioids allowed to come to the market — the DEA heeded calls to address America’s opioid epidemic by reducing nearly all opioid quotas by 25% or more.  This was the first reduction of its kind in over 20 years.  And in November 2017, the DEA again reduced production quotas for nearly all Schedule II prescription opioids by 20% for 2018.  This meant that three powerful, addictive painkillers would see a significant reduction from what was allowed on the market just two years prior.  For example, the reduction resulted in a 31% cut to oxycodone over two years; a 43% cut to hydrocodone over two years; and a 42% cut to fentanyl over two years.  But more work must be done to rein in this epidemic, and the DEA needs more statutory tools to effectively do its job.   

The bipartisan Durbin-Kennedy Opioid Quota Reform Act of 2018 would:

• Direct the DEA to consider the additional factors of opioid diversion, abuse, overdose deaths and public health impacts when establishing annual opioid production quotas, in addition to the existing statutory considerations such as prior-year sales and research needs;

• Require the DEA, if it approves any annual increase in opioid quotas, to explain publicly why the public health benefits of the increase outweigh the potential harmful consequences;

• Reveal trends in manufacturer-level quota increases by having the DEA report anonymized data to Congress on the number of manufacturers that the DEA authorizes to produce opioids each year and how many of those manufacturers’ quotas have increased from the previous year;

• Enable the DEA to issue more granular quota levels by removing a current provision that blocks the DEA from considering variations in dosage forms when setting quotas; and

• Require the DEA to identify strategies to better incorporate data collection and changes in accepted medical practice (such as updated CDC Opioid Prescriber Guidelines) in its quota-setting process.

The Opioid Quota Reform Act of 2018 is supported by the National Association of City and County Health Officials, National Association of Counties, Trust for America’s Health, Safe States Alliance and National Safety Council.

###

WASHINGTON, D.C. - U.S. Sen. John Kennedy (R-La.) and Sen. Brian Schatz (D-Hawaii) introduced an amendment to S. 2155, the Economic Growth, Regulatory Relief and Consumer Protection Act, that makes it easier for consumers to protect their credit and fix mistakes in the wake of the Equifax security breach.

The amendment tasks the Big Three credit reporting agencies – Equifax, Experian and Transunion – with developing an online portal for consumers to check their credit reports and credit scores for free.  Consumers would be able to easily freeze their credit if they find suspicious activity.  They also would be able to find and fix mistakes as well as opt out of having their data shared or sold to third parties.

“The Equifax security breach impacted nearly 150 million people.  The credit reporting agencies know what you’re buying and what you owe on your mortgage.  The least they can do is help you protect yourself from identity thieves,” said Sen. Kennedy.  “This online portal will allow you to look at your credit report 50 times a day if you want to.  It will also allow you to freeze your credit if you suspect someone’s stolen your credit card.”

“Credit reporting agencies operate totally in the dark. They sell personal data about consumers, often get it wrong or leave it exposed to hacks, and then charge people to fix the agencies’ mistakes,” said Senator Schatz. “Our legislation would give consumers control of their own personal information and hold reporting agencies accountable for their own mistakes.”

###